Barr Pharmaceuticals president jumps to competitor Watson
-
- August
- 2
Barr Pharmaceuticals Inc. President and Chief Operating Officer Paul M. Bisaro is leaving the New Jersey-based generic-drug giant to take over as president and chief executive officer at Watson Pharmaceuticals Inc.
Bisaro, 46, is replacing current Watson Chairman, CEO and President Allen Chao, 61, the founder of the 24-year-old generic-drug company, who is retiring as chief executive and president next month but will remain chairman.
“We regret that (Bisaro) has accepted a position with Watson Pharmaceuticals,� Barr Chairman and Chief Executive Officer Bruce L. Downey said in a written statement. Downey will assume Bisaro’s responsibilities on an interim basis, the statement said.
Bisaro joined Barr in 1992 as the company’s general counsel.
Watson and Barr compete with each other in selling versions of some drugs.
Recently, Watson gained approval to begin selling a generic version of Barr’s Seasonale branded birth-control regimen, which limits women’s menstrual periods to four a year.
Both companies have substantial operations in the Lower Hudson Valley. Corona, Calif.-based Watson has a plant in Carmel where about 570 workers are employed. It also has a distribution center in Brewster with some 90 employees.
Barr, based in Woodcliff Lake, has generic-drug research and development operations in Pomona, employing more than 400 workers.
This entry was posted
on Thursday, August 2nd, 2007 at 12:04 pm by David Schepp.
You can follow any responses to this entry through the RSS 2.0 feed.
Share and Enjoy: 
| 
Print
| 
Email
